102 related articles for article (PubMed ID: 9217174)
1. Proteolytic degradation of high molecular weight kininogen in acute thrombotic thrombocytopenic purpura.
Pavord S; Kelton JG; Warner MN; Moore JC; Warkentin TE; Hayward CP
Br J Haematol; 1997 Jun; 97(4):762-7. PubMed ID: 9217174
[TBL] [Abstract][Full Text] [Related]
2. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.
Kelton JG; Warkentin TE; Hayward CP; Murphy WG; Moore JC
Blood; 1992 Nov; 80(9):2246-51. PubMed ID: 1421394
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Warkentin TE; Hayward CP
Br J Haematol; 1996 May; 93(2):421-6. PubMed ID: 8639442
[TBL] [Abstract][Full Text] [Related]
4. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Kelton JG
Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of inhibition of platelet calpain II by human kininogens.
Bradford HN; Schmaier AH; Colman RW
Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
[TBL] [Abstract][Full Text] [Related]
8. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.
Zeigler ZR; Kelton JG; Moore JC; Shadduck RK; Andrews DF; Nath R; Agha M
Bone Marrow Transplant; 1999 Sep; 24(6):641-5. PubMed ID: 10490730
[TBL] [Abstract][Full Text] [Related]
9. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
10. Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.
Bradford HN; Jameson BA; Adam AA; Wassell RP; Colman RW
J Biol Chem; 1993 Dec; 268(35):26546-51. PubMed ID: 8253784
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
12. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK).
Mannhalter C; Lang H
Thromb Haemost; 1988 Dec; 60(3):447-52. PubMed ID: 3238647
[TBL] [Abstract][Full Text] [Related]
13. The blood fluke Schistosoma mansoni cleaves the coagulation protein high molecular weight kininogen (HK) but does not generate the vasodilator bradykinin.
Wang Q; Da'dara AA; Skelly PJ
Parasit Vectors; 2018 Mar; 11(1):182. PubMed ID: 29540224
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
Lian EC
Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
[TBL] [Abstract][Full Text] [Related]
15. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura.
Mikes B; Sinkovits G; Farkas P; Csuka D; Schlammadinger A; Rázsó K; Demeter J; Domján G; Réti M; Prohászka Z
Thromb Res; 2014 Apr; 133(4):616-21. PubMed ID: 24548690
[TBL] [Abstract][Full Text] [Related]
17. High molecular weight kininogen, the extracellular inhibitor of thiol proteases, is deficient in hamsters with muscular dystrophy.
Colman RW; Bradford HN; Warner AH
Thromb Res; 1989 Apr; 54(2):115-23. PubMed ID: 2473540
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
Consonni R; Falanga A; Barbui T
Br J Haematol; 1994 Jun; 87(2):321-4. PubMed ID: 7947274
[TBL] [Abstract][Full Text] [Related]
19. Plasma from patients with thrombotic thrombocytopenic purpura induces activation of human monocytes and polymorphonuclear neutrophils.
Alvarez-Larrán A; Petriz J; Martínez A; Sanz C; Pereira A
Br J Haematol; 2003 Jan; 120(1):129-34. PubMed ID: 12492588
[TBL] [Abstract][Full Text] [Related]
20. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.
Jimenez JJ; Jy W; Mauro LM; Horstman LL; Ahn YS
Br J Haematol; 2001 Jan; 112(1):81-90. PubMed ID: 11167788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
